Finance

Beta
Lists
PEN:BMV
Penumbra Inc
MX$4,775.70
0.00%
(0.00) 1D
Aug 18, 12:09:13 PM GMT-6  ·   MXN
All symbols
SymbolPriceChange% Change
Generating top insights for PEN...
Mkt. cap
12.54B
Avg. vol.
0.00
Volume
0.00
52-wk high
MX$4,911.82
52-wk low
MX$4,775.70
No. of employees
5K
Mkt. cap
12.54B
Avg. vol.
0.00
Volume
0.00
52-wk high
MX$4,911.82
52-wk low
MX$4,775.70
No. of employees
5K
News stories
From sources across the web
Profile
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by yearend. Wikipedia
About Penumbra Inc
CEOAdam Elsesser
Employees4.7K
Founded2004
Headquarters-
SectorMedical device
Websitepenumbrainc.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
339.46M
354.68M
385.38M
374.76M
Cost of goods sold
115.44M
114.27M
123.26M
121.35M
Cost of revenue
115.44M
114.27M
123.26M
121.35M
Research and development expenses
23.22M
22.68M
21.79M
22.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
159.96M
168.90M
181.10M
192.80M
Operating expense
183.18M
191.58M
202.90M
215.18M
Total operating expenses
298.63M
305.85M
326.15M
336.52M
Operating income
40.83M
48.84M
59.23M
38.23M
Other non operating income
-
-
593.00K
-
EBT including unusual items
45.31M
52.32M
63.63M
41.69M
EBT excluding unusual items
45.31M
52.32M
63.63M
41.69M
Income tax expense
40.00K
6.47M
16.29M
9.10M
Effective tax rate
0.09%
12.37%
25.60%
21.84%
Other operating expenses
-
-
-
-
Net income
45.27M
45.85M
47.34M
32.58M
Net profit margin
13.34%
12.93%
12.28%
8.69%
Earnings per share
0.86
0.97
1.18
1.01
Interest and investment income
3.99M
4.36M
4.56M
4.87M
Interest expense
-319.00K
-338.00K
-333.00K
-317.00K
Net interest expenses
3.67M
4.02M
4.23M
4.55M
Depreciation and amortization charges
-
-
-
-
EBITDA
46.34M
51.33M
63.49M
42.81M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer